A phase 1b, open-label study of trebananib plus bevacizumab or motesanib in patients with solid tumours.
about
Targeting angiogenesis in small cell lung cancerA phase I trial of ANG1/2-Tie2 inhibitor trebaninib (AMG386) and temsirolimus in advanced solid tumors (PJC008/NCI♯9041).Molecular Pathways: Deciphering Mechanisms of Resistance to Macrophage-Targeted Therapies.Angiopoietin pathway gene expression associated with poor breast cancer survival.Therapeutic targeting of the angiopoietin-TIE pathway.A network meta-analysis on the efficacy of sixteen targeted drugs in combination with chemotherapy for treatment of advanced/metastatic colorectal cancer.
P2860
A phase 1b, open-label study of trebananib plus bevacizumab or motesanib in patients with solid tumours.
description
2014 nî lūn-bûn
@nan
2014 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
A phase 1b, open-label study o ...... n patients with solid tumours.
@ast
A phase 1b, open-label study o ...... n patients with solid tumours.
@en
A phase 1b, open-label study o ...... n patients with solid tumours.
@nl
type
label
A phase 1b, open-label study o ...... n patients with solid tumours.
@ast
A phase 1b, open-label study o ...... n patients with solid tumours.
@en
A phase 1b, open-label study o ...... n patients with solid tumours.
@nl
prefLabel
A phase 1b, open-label study o ...... n patients with solid tumours.
@ast
A phase 1b, open-label study o ...... n patients with solid tumours.
@en
A phase 1b, open-label study o ...... n patients with solid tumours.
@nl
P2093
P2860
P356
P1433
P1476
A phase 1b, open-label study o ...... n patients with solid tumours.
@en
P2093
Benjamin M Wu
David S Hong
Erik Rasmussen
Greg Friberg
Lee S Rosen
Marilyn Mulay
Michael B Bass
Zhandong D Zhong
P2860
P304
11154-11167
P356
10.18632/ONCOTARGET.2568
P407
P577
2014-11-01T00:00:00Z